BACKGROUND: Minimally invasive cardiac surgery is an attractive approach for both surgeons and patients. This study aims to describe the experience of mitral valve replacement (MVR) with Ma's tri-port totally thoracoscopic cardiac surgery technique (MTCST) and to prove the feasibility and safety of this technique. METHODS: A total of 490 consecutive patients undergoing MVR were divided into MTCST group (MT group, n=267) and conventional median sternotomy group (MS group, n=223). The perioperative characteristics and the follow-up information were recorded and analyzed between the two groups. RESULTS: The in-hospital mortality and re-operation rate were not significant between the two groups. Compared with the MS group, cardiopulmonary bypass time and aortic cross-clamp time were both longer in the MT group while total operative time was similar to the MS group. Patients in the MT group had less pain and required a decreased analgesic administration than that in the MS group. Intraoperative blood loss, perioperative blood transfusion and the postoperative drainage were all significantly reduced in the MT group as compared to the MS group. Mechanical ventilation time, ICU duration, hospitalization time and hospitalization cost were decreased in the MT group. Patients undergoing MVR with MTCST had a higher Medical Treatment Satisfactory Score than those with conventional sternotomy. CONCLUSIONS: MTCST for mitral valve disease was technically safe and feasible. The results showed that MTCST was a suitable minimally invasive alternative to the conventional sternotomy approach and was a desirable approach for patients with mitral valve disease. 2021 Annals of Cardiothoracic Surgery. All rights reserved.
BACKGROUND: Minimally invasive cardiac surgery is an attractive approach for both surgeons and patients. This study aims to describe the experience of mitral valve replacement (MVR) with Ma's tri-port totally thoracoscopic cardiac surgery technique (MTCST) and to prove the feasibility and safety of this technique. METHODS: A total of 490 consecutive patients undergoing MVR were divided into MTCST group (MT group, n=267) and conventional median sternotomy group (MS group, n=223). The perioperative characteristics and the follow-up information were recorded and analyzed between the two groups. RESULTS: The in-hospital mortality and re-operation rate were not significant between the two groups. Compared with the MS group, cardiopulmonary bypass time and aortic cross-clamp time were both longer in the MT group while total operative time was similar to the MS group. Patients in the MT group had less pain and required a decreased analgesic administration than that in the MS group. Intraoperative blood loss, perioperative blood transfusion and the postoperative drainage were all significantly reduced in the MT group as compared to the MS group. Mechanical ventilation time, ICU duration, hospitalization time and hospitalization cost were decreased in the MT group. Patients undergoing MVR with MTCST had a higher Medical Treatment Satisfactory Score than those with conventional sternotomy. CONCLUSIONS: MTCST for mitral valve disease was technically safe and feasible. The results showed that MTCST was a suitable minimally invasive alternative to the conventional sternotomy approach and was a desirable approach for patients with mitral valve disease. 2021 Annals of Cardiothoracic Surgery. All rights reserved.
Authors: Pey-Jen Yu; Hugh A Cassiere; Sophia L Dellis; Rick A Esposito; Nina Kohn; Donna LaConti; Alan R Hartman Journal: J Cardiothorac Vasc Anesth Date: 2014-09-26 Impact factor: 2.628
Authors: Rakesh M Suri; Joseph A Dearani; Tomislav Mihaljevic; W Randolph Chitwood; Douglas A Murphy; Alfredo Trento; Hoda Javadikasgari; Harold M Burkhart; Wiley L Nifong; Richard C Daly; A Marc Gillinov Journal: J Thorac Cardiovasc Surg Date: 2016-02-24 Impact factor: 5.209
Authors: Ernesto Greco; Juan M Zaballos; Luis Alvarez; Stefano Urso; Ivana Pulitani; Rafael Sàdaba; Arantxa Juaristi; Juan J Goiti Journal: J Heart Valve Dis Date: 2008-01
Authors: Paul Tang; Mark Onaitis; Bhargavi Desai; Jeffrey G Gaca; Carmelo A Milano; Mark Stafford-Smith; Donald D Glower Journal: Innovations (Phila) Date: 2013 Sep-Oct
Authors: Pieter R Tuinman; Alexander P Vlaar; Alexander D Cornet; Jorrit J Hofstra; Marcel Levi; Joost C M Meijers; Albertus Beishuizen; Marcus J Schultz; Ab Johan Groeneveld; Nicole P Juffermans Journal: Crit Care Date: 2011-02-11 Impact factor: 9.097